Skip to main content

USANA Health Sciences, Inc.

corporate_fare Company Profile

USANA Health Sciences, Inc.

USNA·NYSE·Life Sciences·CIK 0000896264

USANA Health Sciences, Inc. develops and manufactures high-quality nutritional supplements, functional foods, and personal care products sold globally. Founded in 1992 by Myron W. Wentz, Ph.D., the company focuses on science-based products for long-term health and wellness, emphasizing continuous product innovation and scientific research. In 2025, the company generated $925 million in net sales and had approximately 387,000 active Customers in its core nutritional business. The company operates in 25 geographic markets worldwide, distributing products primarily through a direct selling channel. Mainland China is USANA's largest market, accounting for approximately 41.3% of net sales and approximately 49.9% of core nutritional active Customers. As a U.S.-based multinational corporation, its operating results are influenced by currency fluctuations and economic and political conditions in its global markets. USANA is subject to various laws and regulations in the United States, China, and other operating markets concerning its products and distribution methods. In December 2024, USANA acquired a 78.85% ownership interest in Hiya Health Products, LLC, a direct-to-consumer provider of children's health and wellness products. The company also acquired Rise in 2022 and has since expanded Rise's product offering, distribution channel, and customer base. USANA is a U.S. public company listed on the New York Stock Exchange.

USANA Health Sciences, Inc. (NYSE:USNA) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for USNA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for USNA spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • Q3 Sales Fall 4%, Guidance Cut as Core Customer Base Shrinks 8%
  • USANA's Q2 10-Q confirms a $29.1M Hiya goodwill impairment and a $21.4M net loss
  • USANA Swings to Q2 Loss on $29M Hiya Impairment, Slashes 2026 Guidance
  • Q1 Earnings Decline 20% Amidst Core Customer Losses, Despite Growth in New Segments
  • USANA Health Sciences Q1 Revenue Flat, Profit Drops; Reaffirms FY26 Guidance

Financial Snapshot

Fiscal year ended January 3, 2026
Revenue
$925.26M
Net Income
$10.76M
Diluted EPS
$0.58
Op. Cash Flow
$22.35M
Free Cash Flow
$8.53M
Gross Profit
$724.4M
Operating Income
$37.43M
Cash & Equivalents
$158.38M
Debt / Equity
0.00×
Net Margin
1.2%
Shares Outstanding
18.28M sh
Source: 10-K · filed 2026-03-16 · accession 0000896264-26-000021

Short Interest & Short Volume

5.15 days to cover

FINRA reported short interest of 879,205 shares in USNA as of the October 30, 2026 settlement, a 12.9% increase from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 57.2% of USNA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)879,205 shares as of October 30, 2026
Change vs prior period▲ 12.9%
Days to cover5.15 at avg daily volume of 170,638
Daily short volume (FINRA facilities)57.2% of 28,954 shares on November 20, 2026
5-day average short volume58.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with U →
$12.94
52-week range · as of 2026-08-13 $12.94 – $32.32
Market cap
$239.24M
Volume
158.8K (0.8× avg)
3-mo avg 197.8K
Live data · 2026-11-21 15:15 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed USNA - Latest Insights

USNA
Nov 03, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $14.87
Real-time Price: $12.94 info
Change: -$1.93 (-13%) info
Market Cap: $239.244M info
USNA
Aug 13, 2026, 2:37 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.71
Real-time Price: $12.94 info
Change: -$0.770 (-6%) info
Market Cap: $239.244M info
USNA
Aug 04, 2026, 4:22 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $18.25
Real-time Price: $12.94 info
Change: -$5.31 (-29%) info
Market Cap: $239.244M info
USNA
May 12, 2026, 4:35 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $17.36
Real-time Price: $12.94 info
Change: -$4.42 (-25%) info
Market Cap: $239.244M info
USNA
May 05, 2026, 4:33 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $12.94 info
Change: -$6.32 (-33%) info
Market Cap: $239.244M info
USNA
May 05, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.26
Real-time Price: $12.94 info
Change: -$6.32 (-33%) info
Market Cap: $239.244M info
USNA
Apr 07, 2026, 4:50 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $17.54
Real-time Price: $12.94 info
Change: -$4.60 (-26%) info
Market Cap: $239.244M info
USNA
Mar 16, 2026, 2:57 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $17.72
Real-time Price: $12.94 info
Change: -$4.78 (-27%) info
Market Cap: $239.244M info
USNA
Feb 17, 2026, 8:33 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.09
Real-time Price: $12.94 info
Change: -$10.15 (-44%) info
Market Cap: $239.244M info
USNA
Feb 11, 2026, 4:51 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $21.14
Real-time Price: $12.94 info
Change: -$8.20 (-39%) info
Market Cap: $239.244M info
USNA
Jan 12, 2026, 6:29 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.14
Real-time Price: $12.94 info
Change: -$7.20 (-36%) info
Market Cap: $239.244M info
USNA
Jan 08, 2026, 9:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.57
Real-time Price: $12.94 info
Change: -$6.63 (-34%) info
Market Cap: $239.244M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets